MIMS Learning Live Digital 2024

Welcome to our first MIMS Learning Live Digital series of 2024. We look forward to supporting you with your CPD goals by bringing you three evenings of real-world practical learning covering a range of key clinical areas. Make the most of our expert line-up by asking speakers questions during live Q&A.

AstraZeneca

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide.

With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. The company is based in five different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,700 employees work in research and development, manufacturing, supply, sales and marketing. We supply around 36 different medicines to the NHS.

For more information, please visit www.astrazeneca.co.uk and follow us on Twitter @AstraZenecaUK.

Privacy Policy:  If you have elected to receive information about our products or services, or those of other AstraZeneca companies and wish to opt-out of receiving such information, then you can do so by sending an email to privacyrequests@astrazeneca.com. You should clearly state on all communications: your name, username (if any), registration details (if any) and the name of this website (if any). There is also an unsubscribe link at the bottom of all our non-promotional and promotional emails, that can be clicked if you wish to opt-out.

MIMS Learning

MIMS Learning

Access to a flexible learning platform designed for the busy Primary and Secondary healthcare professional, helping you to stay up to date and easing the pain of the annual appraisal process.

Contact
MIMS Learning
Symprove Ltd

Symprove Ltd

Symprove is a water-based probiotic that delivers billions of live and active bacteria to the gut. The healthy bacteria arrive safely in the gut, surviving the harsh environment of the stomach, before multiplying rapidly, thriving and colonising in the gut. This process has been scientifically proven by independent clinical trials in collaboration with research partners including University College London and King’s College London. With existing studies in IBS and IBD completed, Symprove and its key research partners have several more studies underway, including new research on IBS, which will be published in 2024.

Having gained an impressive and loyal customer base since its launch to the market (9 out of 10 customers would recommend), alongside backing from clinical experts, Symprove allows people to take control of their gut and currently boasts an impressive 4.5* TrustPilot score.

The product is vegan, gluten free and FODMAP-friendly.

Contact us at: hcp@symprove.com

Privacy Policy